Procept BioRobotics 

$19.22
390
+$0.02+0.1% Friday 19:59
+$0.28+1.46%Friday 23:45After hours

Statistics

Day High
19.37
Day Low
18.12
52W High
62.17
52W Low
17.96
Volume
2,054,818
Avg. Volume
1,604,686
Mkt Cap
1.09B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.56
-0.49
-0.41
-0.34
Expected EPS
-0.46325
Actual EPS
N/A

Financials

-31.02%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
308.05MRevenue
-95.57MNet Income

Analyst Ratings

29.75Average Price Target
The highest estimate is 35.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
56%
Hold
33%
Sell
11%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRCT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing in the medical robotics space with Procept BioRobotics' AquaBeam Robotic System for prostate surgery.
Medtronic
MDT
Mkt Cap107.36B
Medtronic offers robotic-assisted surgical solutions, including its Hugo™ robotic-assisted surgery system, competing in the broader field of surgical robotics.
Smith & Nephew
SNN
Mkt Cap12.94B
Smith & Nephew provides advanced surgical robotics for orthopedics, competing in the medical robotics market albeit in a different specialty.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. competes in the surgical robotics market with its ROSA® Robot, focusing on orthopedic surgery, showing the breadth of competition in robotic surgery.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its subsidiary Ethicon, is developing robotic surgery solutions, posing competition in innovation and market share in surgical robotics.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific Corporation competes in the medical devices sector, including endoscopy and urology, areas relevant to Procept BioRobotics' focus.
Sensus Healthcare
SRTS
Mkt Cap50.21M
Sensus Healthcare focuses on non-invasive treatments, offering alternative solutions in the broader scope of medical treatments, including therapies that could compete with surgical interventions.
Globus Medical
GMED
Mkt Cap10.6B
Globus Medical, Inc. specializes in musculoskeletal solutions, including robotic surgery systems, indicating competition in the medical robotics field.
Stryker
SYK
Mkt Cap126.42B
Stryker Corporation is a leader in medical technology, including robotic surgical systems like Mako, competing across various surgical disciplines.

About

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Show more...
CEO
Mr. Larry L. Wood
Employees
756
Country
United States
ISIN
US74276L1052

Listings

0 Comments

Share your thoughts

FAQ

What is Procept BioRobotics stock price today?
The current price of PRCT is $19.22 USD — it has increased by +0.1% in the past 24 hours. Watch Procept BioRobotics stock price performance more closely on the chart.
What is Procept BioRobotics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Procept BioRobotics stocks are traded under the ticker PRCT.
Is Procept BioRobotics stock price growing?
PRCT stock has fallen by -7.99% compared to the previous week, the month change is a -11.39% fall, over the last year Procept BioRobotics has showed a -67.06% decrease.
What is Procept BioRobotics market cap?
Today Procept BioRobotics has the market capitalization of 1.09B
When is the next Procept BioRobotics earnings date?
Procept BioRobotics is going to release the next earnings report on August 04, 2026.
What were Procept BioRobotics earnings last quarter?
PRCT earnings for the last quarter are -0.56 USD per share, whereas the estimation was -0.56 USD resulting in a +0.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Procept BioRobotics revenue for the last year?
Procept BioRobotics revenue for the last year amounts to 308.05M USD.
What is Procept BioRobotics net income for the last year?
PRCT net income for the last year is -95.57M USD.
How many employees does Procept BioRobotics have?
As of July 18, 2026, the company has 756 employees.
In which sector is Procept BioRobotics located?
Procept BioRobotics operates in the Health & Wellness sector.
When did Procept BioRobotics complete a stock split?
Procept BioRobotics has not had any recent stock splits.
Where is Procept BioRobotics headquartered?
Procept BioRobotics is headquartered in San Jose, United States.